PDMA

(redirected from Prescription Drug Marketing Act)
Also found in: Wikipedia.
AcronymDefinition
PDMAProvincial Disaster Management Authority (Pakistan)
PDMAProduct Development & Management Association
PDMAPrescription Drug Marketing Act
PDMAPhiladelphia Direct Marketing Association
PDMAProvincial Disaster Management Agency (Pakistan)
PDMAPharmaceutical and Medical Devices Agency (est. 2004; Japan)
PDMAPacket Division Multiple Access
PDMAPerte de Données Maximum Admissible (French: Maximum Allowable Data Loss)
PDMAPlastic Deformation Magnetic Assembly
PDMAPhilippine Die and Mold Association, Inc (Manila, Philippines)
PDMAPolarisation Division Multiple Access
PDMAPersonalized Digital Museum Assistant
PDMAProvisioning-Driven Memory Administration (Telcordia)
PDMAPublic Discussion of Moderator Actions (internet forums)
PDMAPharmaceutical Drug Manufacturers Association
PDMAPressurized Docking Mating Adapter
PDMAPhase Division Multiple Access
PDMAPolymethylacrylamide
PDMAPrograma de Doctorado en Matemáticas Aplicadas
References in periodicals archive ?
The Prescription Drug Marketing Act of 1987 (PDMA) was signed into law by the President April 12, 1988.
As explained in FDA's 2001 Prescription Drug Marketing Act Report to Congress, the Agency assumed at that time that the ADR would be the initial distributor to which the manufacturer sold the drug, not a distributor that purchased the drug farther down the distribution chain.
Now that the Prescription Drug Marketing Act has been fully implemented, pharmacists and providers have a major role to play in protecting the public from unsafe medicines," says Marv Shepherd, director of the center for pharmacoeconomic studies in the pharmacy college at the University of Texas at Austin.
New YORK -- A federal court has granted a preliminary injunction that results in another delay in the enforcement of a section of the Prescription Drug Marketing Act (PDMA) that the Food and Drug Administration had hoped to impose this month in its war against the spread of counterfeit drugs.
One contentious issue was resolved in June, according to the group, when the FDA announced that it would no longer delay two provisions relating to the drug pedigree requirements of the Prescription Drug Marketing Act of 1987 (PDMA).
For example, the Prescription Drug Marketing Act of 1988 (PDMA) requires biotechnology and pharmaceutical firms to prove they have processes in place to prevent drug diversion.
The FDA, says PhRMA, should take immediate action to implement regulations that require drug wholesalers to provide customers with a system for establishing the sales history of the drugs they sell (as required by the Prescription Drug Marketing Act of 1988).
Full browser ?